Хайдер Варрайч - Сердце, которое мы не знаем. История важнейших открытий и будущее лечения сердечно-сосудистых заболеваний
- Название:Сердце, которое мы не знаем. История важнейших открытий и будущее лечения сердечно-сосудистых заболеваний
- Автор:
- Жанр:
- Издательство:Литагент Альпина
- Год:2021
- Город:Москва
- ISBN:9785961473445
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Хайдер Варрайч - Сердце, которое мы не знаем. История важнейших открытий и будущее лечения сердечно-сосудистых заболеваний краткое содержание
Вы узнаете о строении и функциях сердца и коронарных сосудов, о самых распространенных болезнях, их диагностике, лекарствах, а также о плюсах и минусах популярных методов лечения – катетеризации, кардиостимуляции и электроимпульсной терапии. Книга полна историй из практики автора и его коллег и отсылок к истории медицинской науки.
Хайдер Варрайч объясняет, почему женщины страдают теми же сердечными заболеваниями, что и мужчины, но тип заболевания у них совершенно иной, что общего у коронарных и онкологических заболеваний, как эволюция могла привести нас к настоящей эпидемии ишемической болезни, рассуждает о нынешнем состоянии мировой клинической кардиологии и перспективах ее развития в эпоху внедрения искусственного интеллекта.
Сердце, которое мы не знаем. История важнейших открытий и будущее лечения сердечно-сосудистых заболеваний - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
444
Cuculich P. S., Schill M. R., Kashani R., et al. Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia. New England Journal of Medicine. 2017;377:2325–36.
445
Desai N. R., Bourdillon P. M., Parzynski C. S., et al. Association of the U. S. Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007–2015. Journal of the American Medical Association. 2018;320:63–71.
446
Shen L., Jhund P. S., Petrie M. C., et al. Declining Risk of Sudden Death in Heart Failure. New England Journal of Medicine. 2017;377:41–51.
447
Kober L., Thune J. J., Nielsen J. C., et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. New England Journal of Medicine. 2016;375:1221–30.
448
Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of Implantable Cardioverter Defibrillators in End-of-Life Care. Annals of Internal Medicine. 2004;141:835–8.
449
Goldstein N. E., Mehta D., Siddiqui S., et al. “That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators. Journal of General Internal Medicine. 2008;23 Suppl 1:7–12.
450
Zoll P. M. Resuscitation of the Heart in Ventricular Standstill by External Electric Stimulation. New England Journal of Medicine. 1952;247:768–71.
451
Pycroft L., Aziz T. Z. Security of Implantable Medical Devices with Wireless Connections: The Dangers of Cyber-Attacks. Expert Review of Medical Devices. 2018; 15:403–6.
452
Dyer O. Abbott Laboratories Offers Fix for 745 000 Pacemakers Vulnerable to Hacking. British Medical Journal. 2017;358: j4190.
453
de Moor J. S., Mariotto A. B., Parry C., et al. Cancer Survivors in the United States: Prevalence Across the Survivorship Trajectory and Implications for Care. Cancer Epidemiology, Biomarkers & Prevention. 2013;22:561–70.
454
Drake N. When Hubble Stared at Nothing for 100 Hours. National Geographic. April 2015.
455
Jaiswal S., Fontanillas P., Flannick J., et al. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes. New England Journal of Medicine. 2014;371:2488–98.
456
Stockmann C., Hersh A. L., Sherwin C. M., Spigarelli M. G. Alignment of United States Funding for Cardiovascular Disease Research with Deaths, Years of Life Lost, and Hospitalizations. International Journal of Cardiology. 2014;172: e19–21.
457
Okwuosa T. M., Anzevino S., Rao R. Cardiovascular Disease in Cancer Survivors. Postgraduate Medical Journal. 2017;93:82–90.
458
Steele C. B., Thomas C. C., Henley S. J., et al. Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity-United States, 2005–2014. Morbidity and Mortality Weekly Report. 2017;66:1052–8.
459
Friedenreich C. M., Shaw E., Neilson H. K., Brenner D. R. Epidemiology and Biology of Physical Activity and Cancer Recurrence. Journal of Molecular Medicine. (Berlin). 2017;95:1029–41.
460
Holmes M. D., Chen W. Y., Feskanich D., Kroenke C. H., Colditz G. A. Physical Activity and Survival After Breast Cancer Diagnosis. Journal of the American Medical Association. 2005;293:2479–86.
461
Hua X., Phipps A. I., Burnett-Hartman AN, et al. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients with Colorectal Cancer in Relation to Tumor Markers and Survival. Journal of Clinical Oncology. 2017;35:2806–13.
462
Omer Z. B., Hwang E. S., Esserman L. J., Howe R., Ozanne E. M. Impact of Ductal Carcinoma In Situ Terminology on Patient Treatment Preferences. Journal of the American Medical Association. Internal Medicine. 2013;173:1830–1.
463
Pentagon Gets ISIS Metaphor Wrong, Critics Say. January 2016. www.npr.org/2016/01/26/464399975/how-to-keep-isis-from-spreading-is-still-up-for-debate.
464
Greene S. J., Butler J., Albert N. M., et al. Medical Therapy for Heart Failure with Reduced Ejection Fraction: The CHAMP-HF Registry. Journal of the American College of Cardiology. 2018;72:351–66.
465
Warraich H. Failing Heart Failure Patients. New York Times. August 2015.
466
Thomson J. G. Provisional Report on the Autopsy of L. W. (Louis Washkansky). South African Medical Journal. 1967;41:1277–8.
467
Kirklin J. K., Pagani F. D., Kormos R. L., et al. Eighth Annual INTERMACS Report: Special Focus on Framing the Impact of Adverse Events. Journal of Heart and Lung Transplantation. 2017;36:1080–6.
468
Warraich H. J., Kaltenbach L. A., Fonarow G. C., Peterson E. D., Wang TY. Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study. Circulation: Cardiovascular Quality and Outcomes. 2018;11: e004528.
469
Cooley D. A. Some Thoughts About the Historic Events That Led to the First Clinical Implantation of a Total Artificial Heart. Texas Heart Institute Journal. 2013;40:117–9.
470
Altman L. The Feud. New York Times. 2007.
471
Maugh T. Denton Cooley, Texas Surgeon Who Performed First Successful Heart Transplant in U.S., Dies at 96. Los Angeles Times. 2016.
472
A Bitter Feud: Two Great Surgeons at War over the Human Heart. Life. April 1970.
473
Cooley. Some Thoughts About the Historic Events.
474
Altman L. The Feud.
475
Там же.
476
Dr. Denton Cooley at 95: The Legend Speaks in a Video Interview. July 2016. www.houstonchronicle.com/local/prognosis/article/Cooley-at-95-Some-tidbits-froman-interview-8387536.php.
477
Cooley D. 10,000 Hearts: A Surgeon’s Memoir. Austin: Briscoe Center for American History, University of Texas; 2012.
478
Dr. Denton Cooley at 95.
479
Maugh T. Denton Cooley, Texas Surgeon.
480
Miller L. W., Rogers J. G. Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review. JAMA Cardiology. 2018;3:650–8.
481
Jakovljevic D. G., Yacoub M. H., Schueler S., et al. Left Ventricular Assist Device as a Bridge to Recovery for Patients with Advanced Heart Failure. Journal of the American College of Cardiology. 2017;69:1924–33.
482
McIlvennan C.K., Wordingham S. E., Allen L. A., et al. Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians. Journal of Cardiac Failure. 2017;23:708–12.
483
Diop M. S., Rudolph J. L., Zimmerman KM, Richter M. A., Skarf L. M. Palliative Care Interventions for Patients with Heart Failure: A Systematic Review and Meta-Analysis. Journal of Palliative Medicine. 2017;20:84–92.
484
Warraich H. J., Hernandez A. F., Allen L. A. How Medicine Has Changed the End of Life for Patients with Cardiovascular Disease. Journal of the American College of Cardiology. 2017;70:1276–89.
485
Warraich H. J., Mentz R. J., Hernandez A. F. Paving a Better Path for Patients Dying of Heart Disease. Circulation. 2018;137:1216–7.
486
Doctor Considers the Pitfalls of Extending Life and Prolonging Death. January 2017. www.npr.org/sections/health-shots/2017/01/30/512426568/doctorconsiders-the-pitfalls-of-extending-life-and-prolonging-death.
487
Warraich, Hernandez, Allen. How Medicine Has Changed the End.
488
Goldstein N.E, Lampert R., Bradley E., Lynn J., Krumholz H. M. Management of Implantable Cardioverter Defibrillators in End-of-Life Care. Annals of Internal Medicine. 2004;141:835–8.
489
Goldstein N. E., Mehta D., Siddiqui S., et al. “That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators. Journal of General Internal Medicine. 2008;23 Suppl 1:7–12.
490
Singh G. K., Siahpush M., Azuine R. E., Williams S. D. Widening Socioeconomic and Racial Disparities in Cardiovascular Disease Mortality in the United States, 1969–2013. International Journal of MCH and AIDS. 2015;3:106–18.
491
Rosenson R. S., Hegele R. A., Fazio S., Cannon CP. The Evolving Future of PCSK9 Inhibitors. Journal of the American College of Cardiology. 2018;72:314–29.
492
Ray K. K., Landmesser U., Leiter L. A., et al. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol. New England Journal of Medicine. 2017;376:1430–40.
493
Singh, Siahpush, Azuine, Williams. Widening Socioeconomic and Racial Disparities.
Интервал:
Закладка:
